# To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications

> **NCT01103739** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** PF-04531083
- **DRUG:** simvastatin
- **DRUG:** PF-04531083
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT01103739
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103739, "To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT01103739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*